Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
One of the latest ideas circulating around Gaza’s postwar transition is the creation of Hamas-free camps—or, in the more cautious language of planners, “temporary communities”—inside the ...
Matt Bowen looks at three rookie receivers he has his eye on in mock drafts that you'll want in lineups this fall.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results